Sasanlimab (PF-06801591) added to BCG therapy significantly improved outcomes for patients with BCG-naive, high-risk ...

Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or ...

Bladder cancer patients given an immunotherapy ... Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also being trialled in other cancers.

The subtypes investigated in bladder cancer were CK19 ... but the results of a pilot study are encouraging. Detecting cancer cells in the bloodstream is expected to provide great information ...

In this case, the cancer cells in the brain would be lung cancer cells, not cancerous brain cells. Conversely, a person may have primary lung cancer and second primary brain cancer that is unrelated.

deeper colors reflect higher enrichment scores and a higher content of that cell type. A malignant score of 1 classifies a spot as Malignant, 0 as Normal, and intermediate scores as Mixed. 4.3 ...

After hours: January 15 at 4:00:11 PM EST Loading Chart for INBX ...

After hours: January 6 at 4:01:37 p.m. EST ...